 E Canada Now | Genentech's Gamble BusinessWeek - by Arlene Weintraub In the 12 years since Arthur D. Levinson took over as CEO of Genentech (DNA), the company has released seven new drugs, including three multibillion-dollar cancer treatments. Advisory Panel Rejects New Use for Cancer Drug UPDATE 2-US panel rejects Avastin for treating breast cancer |